These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 10110735)

  • 1. Charter reports net loss for second quarter.
    Nemes J
    Mod Healthc; 1991 May; 21(20):9. PubMed ID: 10110735
    [No Abstract]   [Full Text] [Related]  

  • 2. Charter reports $130 million loss for year.
    Nemes J
    Mod Healthc; 1991 Dec; 21(50):7. PubMed ID: 10115292
    [No Abstract]   [Full Text] [Related]  

  • 3. Charter showing signs of turnaround.
    Nemes J
    Mod Healthc; 1991 Aug; 21(33):8. PubMed ID: 10112391
    [No Abstract]   [Full Text] [Related]  

  • 4. Charter reaches tentative agreement on debt deal.
    Nemes J
    Mod Healthc; 1991 Aug; 21(34):8. PubMed ID: 10112411
    [No Abstract]   [Full Text] [Related]  

  • 5. Charter trying to restructure its debt to stave off default.
    Kim H
    Mod Healthc; 1991 Jan; 21(3):2-3. PubMed ID: 10108733
    [No Abstract]   [Full Text] [Related]  

  • 6. Charter's earnings better than expected.
    Lutz S
    Mod Healthc; 1992 Nov; 22(47):6. PubMed ID: 10122244
    [No Abstract]   [Full Text] [Related]  

  • 7. January surge makes Charter one of top-performing stocks.
    Lutz S
    Mod Healthc; 1993 Feb; 23(6):18. PubMed ID: 10123719
    [No Abstract]   [Full Text] [Related]  

  • 8. Bondholder pact will take Charter 'public' again.
    Nemes J
    Mod Healthc; 1991 Oct; 21(42):3. PubMed ID: 10114225
    [No Abstract]   [Full Text] [Related]  

  • 9. Charter's losses raise debt concerns.
    Kim H
    Mod Healthc; 1990 May; 20(20):3. PubMed ID: 10104874
    [No Abstract]   [Full Text] [Related]  

  • 10. Charter pares 1st quarter loss.
    Lutz S
    Mod Healthc; 1992 Feb; 22(7):10. PubMed ID: 10116222
    [No Abstract]   [Full Text] [Related]  

  • 11. NME posts 35% higher income in 3rd quarter as psych unit recovers.
    Nemes J
    Mod Healthc; 1993 Mar; 23(13):19. PubMed ID: 10124822
    [No Abstract]   [Full Text] [Related]  

  • 12. Despite psychiatric division woes, NME's 2nd quarter income rises 7%.
    Nemes J
    Mod Healthc; 1992 Jan; 22(2):10. PubMed ID: 10115795
    [No Abstract]   [Full Text] [Related]  

  • 13. Charter to repay insurers.
    Lutz S
    Mod Healthc; 1995 May; 25(19):4. PubMed ID: 10142257
    [No Abstract]   [Full Text] [Related]  

  • 14. NME execs ponder future, report $429.9 million loss.
    Lutz S
    Mod Healthc; 1994 Aug; 24(31):4. PubMed ID: 10135252
    [No Abstract]   [Full Text] [Related]  

  • 15. Huge write-off for psychiatric operations causes NME's first quarterly loss in 6 years.
    Nemes J
    Mod Healthc; 1992 Aug; 22(31):3. PubMed ID: 10119606
    [No Abstract]   [Full Text] [Related]  

  • 16. Psych unit keeps hurting, and NME feels the loss.
    Nemes J
    Mod Healthc; 1993 Jan; 23(1):10. PubMed ID: 10123181
    [No Abstract]   [Full Text] [Related]  

  • 17. Community Psych earnings drop 98% in third quarter.
    Lutz S; Nemes J
    Mod Healthc; 1991 Oct; 21(40):8. PubMed ID: 10114192
    [No Abstract]   [Full Text] [Related]  

  • 18. Charter expects $210 million loss.
    Kim H
    Mod Healthc; 1991 Jan; 21(1):1-2. PubMed ID: 10108297
    [No Abstract]   [Full Text] [Related]  

  • 19. Charter Medical to divest 12 properties.
    Pallarito K
    Mod Healthc; 1990 Aug; 20(33):3-4. PubMed ID: 10105808
    [No Abstract]   [Full Text] [Related]  

  • 20. NME totaling costs of psych woes.
    Lutz S
    Mod Healthc; 1993 Oct; 23(43):20. PubMed ID: 10129357
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.